SAMe
S-Adenosylmethionine · S-Adenosyl-L-Methionine · Ademetionine
Snapshot
| Indications | Contraindications |
|---|---|
S-adenosylmethionine (SAMe), also called ademetionine, is the body's principal methyl donor, supporting methylation reactions in brain and liver. Supplementation is used for depressive symptoms, where a meta-analysis found monotherapy superior to placebo1, and for primary biliary cholangitis alongside ursodeoxycholic acid3. Typical users are adults with mild-to-moderate depressive symptoms.
Added to antidepressants, SAMe did not differ from placebo, and against antidepressants alone it showed no significant difference1. In a 2022 laboratory study of biological rhythms, excess SAMe was catabolized to adenine and methylthioadenosine, which inhibit methylation; no human trial has tested this. Products listing SAMe are mostly tablets or capsules; see Form comparison.
Antidepressant cautions are about coordination: per product labels, SAMe is not to be combined with antidepressants unless under close supervision of a health care professional5. The Italian label reports serotonin syndrome with clomipramine and advises caution with selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants6.
Last updated October 15, 2026. Read how we make monographs.
In the full monograph
30 sources, 22 studies
- When to useThe situations practitioners use it for, each with the reason and the study behind it.
- SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
- InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
- Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
- How it worksWhat it is and how it works in the body, in plain terms.
- Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
- Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
- Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.
Sources
- 1Efficacy and acceptability of S-adenosyl-L-methionine (SAMe) for depressed patients: A systematic review and meta- analysis.pubmed.ncbi.nlm.nih.govLimveeraprajak, Nakhawatchana, Visukamol et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2024 · Pubmed
- 2Oral Administration of S-Adenosylmethionine (SAMe) and Lactobacillus Plantarum HEAL9 Improves the Mild-To-Moderate Symptoms of Depression: A Randomized, Double-Blind, Placebo-Controlled Study.pubmed.ncbi.nlm.nih.govSaccarello, Montarsolo, Massardo et al. · The primary care companion for CNS disorders · 2020 · Pubmed
- 3Effect of S-adenosyl-L-methionine on liver biochemistry and quality of life in patients with primary biliary cholangitis treated with ursodeoxycholic acid. A prospective, open label pilot study.pubmed.ncbi.nlm.nih.govWunsch, Raszeja-Wyszomirska, Barbier et al. · Journal of gastrointestinal and liver diseases : JGLD · 2018 · Pubmed
- 4S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.pubmed.ncbi.nlm.nih.govSharma, Gerbarg, Bottiglieri et al. · The Journal of clinical psychiatry · 2017 · Pubmed
- 5US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
- 6Foreign drug labelema.europa.euThe label of a medicine with this ingredient approved outside the US (a regulator's Summary of Product Characteristics or prescribing information, or the manufacturer's official instructions). Labels in German, Italian or Russian are quoted in English translation, marked as translated. What one country approved for one product, not US approval